-
EP2322198
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2322198
| EP2322198 - Pharmaceutical compositions including low dosages of desmopressin [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 13.01.2023 Database last updated on 02.11.2024 | Most recent event Tooltip | 13.01.2023 | Withdrawal of application | published on 15.02.2023 [2023/07] | 13.01.2023 | Change - applicant | published on 15.02.2023 [2023/07] | Applicant(s) | For all designated states Ferring B.V. Polarisavenue 144 2132 JX Hoofddorp / NL | [2023/07] |
| Former [2014/10] | For all designated states Reprise Biophamaceutics, LLC 120 North Main Street, Suite 400 New York, NY 10956 / US | ||
| Former [2011/37] | For all designated states Allergan, Inc. 2525 Dupont Drive Irvine, CA 92612 / US | ||
| Former [2011/20] | For all designated states Reprise Biopharmaceutics, LLC 120 North Main Street Suite 400 New City NY 10956 / US | Inventor(s) | 01 /
Fein, Seymour N. 476 Canoe Hill Road New Canaan CT 06840 / US | [2011/20] | Representative(s) | Prins, Hendrik Willem, et al Arnold & Siedsma Bezuidenhoutseweg 57 2594 AC The Hague / NL | [N/P] |
| Former [2011/51] | Kupecz, András Ferenc, et al Simmons & Simmons LLP Claude Debussylaan 247 1082 MC Amsterdam / NL | ||
| Former [2011/20] | Lock, Graham James, et al Fry Heath & Spence LLP The Gables Massetts Road Horley Surrey RH6 7DQ / GB | Application number, filing date | 11000468.6 | 10.11.2003 | [2011/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2322198 | Date: | 18.05.2011 | Language: | EN | [2011/20] | Classification | IPC: | A61K38/11, A61P13/00 | [2011/20] | CPC: |
A61K9/2018 (EP);
A61K38/095 (EP);
A61K9/0019 (EP);
A61K9/0056 (EP);
A61P13/00 (EP);
A61P13/02 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2011/20] | Title | German: | Pharmazeutische Zusammensetzungen mit niedrigen Dosen von Desmopressin | [2011/20] | English: | Pharmaceutical compositions including low dosages of desmopressin | [2011/20] | French: | Compositions pharmaceutiques comportant de la desmopressine faiblement dosee | [2011/20] | Examination procedure | 02.01.2023 | Application withdrawn by applicant [2023/07] | Appeal following examination | 05.05.2017 | Appeal received No. J0009/17 | 16.05.2018 | Date of oral proceedings | 11.06.2018 | Minutes of oral proceedings despatched | Parent application(s) Tooltip | EP03781836.6 / EP1689419 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20030781836) is 17.03.2009 | Fees paid | Renewal fee | 12.05.2011 | Renewal fee patent year 03 | 12.05.2011 | Renewal fee patent year 04 | 12.05.2011 | Renewal fee patent year 05 | 12.05.2011 | Renewal fee patent year 06 | 12.05.2011 | Renewal fee patent year 07 | 12.05.2011 | Renewal fee patent year 08 | 23.11.2011 | Renewal fee patent year 09 | 26.11.2012 | Renewal fee patent year 10 | 27.11.2013 | Renewal fee patent year 11 | 26.11.2014 | Renewal fee patent year 12 | 30.11.2015 | Renewal fee patent year 13 | 28.11.2016 | Renewal fee patent year 14 | 27.11.2017 | Renewal fee patent year 15 | 27.11.2018 | Renewal fee patent year 16 | 27.11.2019 | Renewal fee patent year 17 | 27.11.2020 | Renewal fee patent year 18 | 18.11.2021 | Renewal fee patent year 19 | Penalty fee | Additional fee for renewal fee | 30.11.2022 | 20 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Stay/Interruption | 18.05.2011 | Stay of proceedings | [2011/24] | 18.05.2011 | Stay of proceedings | [2022/43] | 02.01.2023 | Resumption of proceedings | [2022/43] | Cited in | by applicant | US5466464 | US6024981 | US6221392 | US6200604 | GB1548022 | WO0061117 | WO0044351 | US5188825 | US5827541 | US6156339 | US5738875 | US5837287 | US5976577 | US5631023 | WO9323017 | GB2111423 | GB2119246 | GB2114440 | GB2111184 | WO9921579 | US5925730 | US4072668 | WO2005046707 | US2003003566 | - FJELLESTAD-PAULSEN A. ET AL., CLIN. ENDOCRINOL., (1993), vol. 38, pages 177 - 82 |